News About: Goverment
59 additional drugs to incentive dispensing items.
The Health Insurance Review Agency (HIRA) announced on June 16 that 59 more drugs would be included to the incentive items for a substituted dispensing after approving their bio-equivalencies. Now, as of May 27 the t...
4 groups jointly agreed to measure against current issues.
4 medical and pharmaceutical organizations including Korea Pharmaceutical Association(KPA), Korea Medical Association(KMA), Korea Dental Medical Association(KDMA) and Korea Oriental Medical Association(KOMA) concurred...
Drug packages to show appropriate descriptions for consumers.
The KFDA plans to improve descriptions for all drug packages in order to provide better drug informations for consumers and to prevent drug abuse and misuse.
In the OTC drug study workshop on June 12 led by Prof. ...
MOHW's more substantiated NHI development plans.
The MOHW presented the mid and long term development plans on June 17 for the national health insurance to the National Assembly Standing Committee through the NHI development panels (hereinafter called Panel).
Wit...
KFDA okayed Iressa sales in Korea.
The KFDA approved Iressa, a non-small lung cancer drug developed by Astra Zeneca on June 14 after clearing the comparative dissolution test problems.
The registration in Korea will be the 6th after Japan, America, ...
648 expensive drugs to put under major supervision.
Prescriptions for 648 expensive drugs will put under the special checking list and the government will take a special investigation for the medical institutions where these expensive drugs are habitually prescribed.
...
MOHW to legislate administrative measures against false and unfair bills.
The MOHW disclosed the revised draft of the working rules of the pharmaceutical affairs act on June 12 that adjusted and set up the standards for the administrative measures to the pharmacy against false and unfair bi...
Kyeongin KFDA was elected 2002 outstanding organization.
The KFDA appraised all affiliate organizations for the purpose of activating a creative and efficient working attitude of all officials through their policy implementing efforts and enthusiasm, and finally decided the...
KFDA to switch its penalty regulations to heavier fines
The Korea Food and Drug Administration unveiled its plan that those who will be found to violate the current Pharmaceutical Affairs Law should be subject to heavier fines as implemented in advanced countries instead o...
KHIPA to drive strategic projects for export promotion.
In an attempt to encourage drug exports, the Korea Health Industry Promotion Agency (KHIPA), decided 2003 business projects after selecting a potential business item to improve the world trade balance in the health in...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
